1KHORANA A A, FRANCIS C W, CULAVA E, et al. Thromboembolism in hospitalized neutropenic cancer patients [ J ]. J Clin Oncol, 2006, 24 (3) :484-490.
2GOLDHABER S Z, TAPSON V F. A prospective registry of 5415 patients with ulstrasound-confirmed deep vein thrombosis[ J]. Am J Cardiol, 2004, 93(2) :259-262.
3RICKLES F R, LEVINE M N. Venous thromboembolism in malignancy and malignancy in venous thromboembolism[ J]. Haemostasis, 1998, 28 ( S3 ) :43-49.
4LEVINE M N, LEE A Y, KAKKAR A K. Thrombosis and cancer [ M ]. Alexandria: Am Soc Clin Oncol Ed Book ,2005:748.
5KROGER K, WEILAND D, OSE C, et al. Risk factor for venous thrombolic events in cancer patients [ J]. Am Oncol, 2006, 17 (2) :297-303.
6MAIOLO A,TUA A,GRIGNAI G. Hemostasis and cancer : tumor cells induce the expression of tissue factor-like procoagulant activity on endothelia cells [ J ]. Haematologica, 2002, 87 ( 6 ) : 624- 628.
7FERNANDEZ PM, PATIERNO SA, RICKLES FR. Tissue factor and fibrin in tumor angiogenesis [ J ]. Semin Thromb Hemost, 2004, 30(1) :31-44.
8HAIM N,LANIR N, HOFFMAN R, et al. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism[ J]. Am J Med, 2001, 110 (2) :91- 96.
9LYMAN G H, KHORANA A A, FALANGA A, et al. American Society of Clinical Oncology guideline : recommendation for venous thromboembolism prophylaxis and treatment in patients with cancer [J]. J Clin Oncol, 2007, 25(34):5490-5505.
